General Information
Flu, or influenza, is a contagious respiratory infection caused by a variety of flu viruses. Symptoms of flu involve muscle aches and soreness, headache, and fever. Type A flu virus is constantly changing and is generally responsible for the large flu epidemics.
Influenza A can be divided into different subtypes based on the combination of two proteins on the viral surface: hemagglutinin (H) and neuraminidase (N).
Pair Recommendation | IC (Capture-Detection):1B5-6 ~ 3A9-8 |
Purity | >95%, determined by SDS-PAGE |
Buffer Formulation | PBS, pH7.4. |
Storage |
Store it under sterile conditions at -20℃ to -80℃ upon receiving. Recommend to aliquot the protein into smaller quantities for optimal storage. |
Product Name | Cat. No | Clone ID |
Flu A | AB0023-1 | 1F10-1 |
AB0023-2 | 1B5-6 | |
AB0023-3 | 3A9-8 |
Note: Bioantibody can customized quantities per your need.
1.Senne D A , Panigrahy B , Kawaoka Y , et al. Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: amino acid sequence at the HA cleavage site as a marker of pathogenicity potential.[J]. Avian Diseases, 1996, 40(2):425-437.
2.Benton D J , Gamblin S J , Rosenthal P B , et al. Structural transitions in influenza haemagglutinin at membrane fusion pH[J]. Nature, 2020:1-4.
3.1. Urai C, Wanpen C. Evolution of Therapeutic Antibodies, Influenza Virus Biology, Influenza, and Influenza Immunotherapy. Biomed Res Int. 2018.
4.2. Florian K. The human antibody response to influenza A virus infection and vaccination. Nature reviews immunology. 2019, 19, 383-397.